Abstract
With diagnostic criteria for hypertension shifting from 140 mmHg to 130 mmHg globally, an estimated number of 300 million people in China would be newly diagnosed if the criteria is applied. However, the premature use of antihypertensive drugs on these people will result in unnecessary economic burden. This study aims to explore the effectiveness and cost-effectiveness of non-pharmacological interventions for prehypertensive patients, and to suggest potential models for community-based chronic diseases management in China.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
